Blog

New Partnership to Advance Treatments for Brain Disease

Posted on March 15, 2018

On Monday, HDSA announced a partnership with the ALS Association and Teva Pharmaceuticals on a project to help identify new…

Read More

Interpreting this Week’s News: Data from the First Phase of the Ionis-Roche Trial

Posted on March 8, 2018

This week, Ionis Pharmaceuticals shared data from the successful safety trial for their huntingtin-lowering drug. The data confirms what was…

Read More

CHDI’s Huntington’s Disease Conference in Palm Springs

Posted on March 1, 2018

This week in Palm Springs, California marks the 13th Annual HD Therapeutics Conference. This yearly conference draws academic and industry…

Read More

Interpreting this Week’s News: Hope for Gene Therapy, and How to Get it to the Brain

Posted on February 22, 2018

Delivery of genetic therapies to the brain is one of the biggest challenges facing researchers in many fields of neurological…

Read More

Interpreting This Week’s News: Fighting Cancer…With HD?

Posted on February 15, 2018

Research studies in recent years have shown that people with Huntington’s Disease and related hereditary CAG repeat disorders have lower…

Read More

First HD-COPE Meeting

Posted on February 8, 2018

The first meeting of the Huntington’s Disease Coalition for Patient Engagement (HD-COPE) took place in London this week. HD-COPE unites…

Read More